Omnicell Stock
Omnicell, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Randall A. Lipps
- Employees
- 3,485
- Market cap
- $1.6 B
- IPO
- 07/08/2001
Omnicell, Inc. is a healthcare technology company operating in the United States and internationally within the Medical - Healthcare Information Services industry. Headquartered in Fort Worth, the company was incorporated in 1992 and went public on the NASDAQ on August 7, 2001. The firm provides comprehensive…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Omnicell stock: price history
1D
-1.6%
1W
-1.2%
1M
+9.1%
6M
-7.5%
YTD
-21.9%
1Y
+16.8%
2Y
-16.8%
5Y
-77.6%
10Y
-0.7%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~158% stronger price swings than usual
Ask the agents about Omnicell
Analyst assessment of Omnicell
PRICE TARGET LOW
US$50.00
CONSENSUS
US$56.67
MEDIAN
US$55.00
PRICE TARGET HIGH
US$65.00
0
STRONG BUY
9
BUY
10
HOLD
0
SELL
0
STRONG SELL
19
TOTAL · Hold
As of: 03/08/2026
Omnicell stock metrics
P/E
41.4
P/B
1.25
EV/EBITDA
10.3
RETURN ON EQUITY
1.9%
NET MARGIN
7.8%
DEBT/EQUITY
0.15
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
96.9%
FLOAT SHARES
44,063,355
AVG. DAILY VOLUME (30D)
505,689
Insider transactions (SEC)
LIPPS RANDALL A
Njoku Nnamdi
Njoku Nnamdi
Manley Corey J
NUTT BRIAN H.
Institutional holders
Comparable stocks
Frequently asked questions about Omnicell stock
What does Omnicell do?
Omnicell, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Randall A. Lipps, the company employs around 3,485 people.
The IPO was on 07/08/2001; the stock trades on NASDAQ under the ticker OMCL.
What do analysts say about Omnicell stock?
19 analysts rate the stock, the consensus is Hold (as of 03/08/2026).
The average price target is US$56.67, ranging from US$50.00 to US$65.00, with a median of US$55.00.
This is an external assessment, not a statement by Market Jury.
When does Omnicell report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 158% stronger than usual.
Does Omnicell pay a dividend?
No, Omnicell currently does not pay a dividend.
Which stocks are comparable to Omnicell?
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get Omnicell stock analyzed?
Clicking "Analyze stock" lets five strategies assess Omnicell against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.